A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
·
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
OTHER
·

Directory Results for 6-Br-5methylindirubin-3?oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis. Current to 6-Bromohexanoyl chloride 97% Sigma-Aldrich

6-Br-5methylindirubin-3?oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis. Current
6-Bromo-2-naphthyl--D-galactopyranoside - Santa Cruz bb
6-bromo-3-(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene-1,3-dihydro-(3Z)-2H-indol2-one; GSK 3 IX; MLS 2052; 6-Bromoindirubin-3'-oxime;
6-Bromohexanoyl chloride 97% Sigma-Aldrich